Boca Raton’s LGM Pharma Finalizes Lease Agreement as Part of Nexgen Pharma Acquisition

After acquiring Nexgen Pharma as part of its expansion into the pharmaceutical manufacturing industry, Boca Raton-based LGM Pharma recently signed a lease to use a 33,488-square-foot warehouse space to accommodate the acquisition.

NAI/Merin Hunter Codman, a leading South Florida commercial real estate firm, helped negotiate terms of the lease agreement, which features a 7-year industrial lease at 2741-2745 Dow Ave. in Tustin, CA. To complete the deal, Jeffrey A. Cebula, Senior Associate of NAI/Merin Hunter Codman’s Tenant Representation Division, partnered with the Executive Vice President, Michael Arnold and Brian Childs, the Executive Managing Director of NAI Capital Commercial’s Tenant Consulting Group on the lease agreement.

“I first approached Jeff, who I met at various Business Development Board of Palm Beach County events, about a modest industrial space needed in California due to LGM’s acquisition and planned growth of our new Drug Manufacturing Division,” says Hamilton Lenox, Senior Vice President of Business Development for LGM. “Despite California’s Covid-19 lockdown challenges, our space needs changed from an initial 2,500 square feet to over 30,000, and Jeff, being based in South Florida, was able to identify, negotiate, and finalize an industrial lease across the country, meeting LGM’s very specific location, industrial and budget requirements, all within a critical timeframe.”

LGM Pharma acquired Nexgen Pharma, a development and drug product contract manufacturing business, in July of 2020 to unite LGM Pharma’s global leadership in API sourcing, distribution and supply chain management with Nexgen Pharma’s comprehensive drug product CDMO services.

The move allows LGM Pharma, a leading provider of comprehensive active pharmaceutical ingredient (API) sourcing and drug product contract development and manufacturing (CDMO) solutions, the capability to help its pharmaceutical and biotechnology customers accelerate and optimize new product launches from the early stages of research and development to clinical trials through manufacturing, regulatory submission, commercialization and distribution.

You May Also Like
Colorful Handprints Bring Hope

Hyundai Donates $100K to Joe DiMaggio Children’s Hospital

Read More
Broward Health Boosts Training with $500K Upgrade

Broward Health Levels Up to Next-Gen Simulation Center

Read More
Holy Cross Hospital the Latest to Propose New Emergency Department in Broward

Plans are under review for an outpatient center and ER to be built on a property in Fort Lauderdale that’s owned by the hospital.

Read More
Haller Foundation Gifts Whopping $5.2 Million to Broward Health Foundation

The funds will go toward building two new labs at Broward Health Medical Center in Downtown Fort Lauderdale.

Read More
Other Posts
Young, Bright & Boardroom Bound

Meet Emerge Broward’s Most Promising Young Professionals

Read More
Fort Lauderdale Banker Takes the Lead in Shaping Florida’s Financial Future

Locality Bank’s Keith Costello Tapped to Lead Florida Bankers Association

Read More
A Fix for the Fixer-Uppers: Florida Rewrites Its Condo Law Before the Market Cracks

Tens of thousands of condo owners have been blindsided by sudden special assessments, skyrocketing HOA fees, and panicked boards scrambling to comply.

Read More
Quiet Power Move: DayMark Lands in Fort Lauderdale with $350M Under Management

DayMark Wealth Partners has expanded into South Florida with a newly onboarded team managing $350 million in client assets.

Read More